
Nuedexta
Brand for: Dextromethorphan-quinidine
My Prescription
Payment
Select pharmacy




$265.41
Print or send this coupon to your phone
About Nuedexta
Drug Details
Nuedexta is a prescription medication used to manage pseudobulbar affect (PBA) in adults, a condition characterized by sudden, uncontrollable episodes of laughing or crying. This medication combines two active ingredients: dextromethorphan, which acts as a sigma-1 receptor agonist and NMDA antagonist, and quinidine, which enhances the effectiveness of dextromethorphan. Although the precise mechanism by which dextromethorphan alleviates symptoms of PBA is not fully understood, quinidine supports its action. Nuedexta is typically administered orally twice daily. While taking this medication, some individuals may experience side effects such as diarrhea, dizziness, and cough. Always consult with a healthcare professional before starting or modifying any medication regimen.
Price history for Nuedexta (brand) & Dextromethorphan-quinidine (generic)
60 Capsules, 20-10MG
Average retail price for Nuedexta
Average retail price for Dextromethorphan-quinidine
Average SaveHealth price for Dextromethorphan-quinidine
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Nuedexta is $1467.43 using the SaveHealth savings card. That's an average savings of 26.07% on Nuedexta with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Nuedexta (Dextromethorphan-quinidine) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 20-10MG | 60 Capsules | $860.22 | $14.34 |
Nuedexta FAQs
Nuedexta is used to treat pseudobulbar affect (PBA), a condition characterized by sudden, uncontrollable episodes of crying or laughing that are disproportionate or inappropriate to the situation.
Nuedexta is not classified as a mood stabilizer. It is a medication used primarily to treat pseudobulbar affect (PBA), a condition characterized by sudden, uncontrollable episodes of crying or laughing.
Nuedexta is not specifically used to treat dementia. It is primarily prescribed for the treatment of pseudobulbar affect (PBA), a condition characterized by sudden, uncontrollable episodes of crying or laughing, which can occur in individuals with certain neurological conditions, including some types of dementia. However, it is not a treatment for the underlying symptoms of dementia itself.
NUEDEXTA is a combination medication that contains dextromethorphan and quinidine. It is primarily used to treat pseudobulbar affect (PBA), a condition characterized by sudden, uncontrollable episodes of crying or laughing.
Nuedexta is not specifically approved for treating Alzheimer's disease. It is primarily used to treat pseudobulbar affect (PBA), a condition characterized by sudden, uncontrollable episodes of crying or laughing. However, some healthcare providers may consider its use off-label for managing certain behavioral symptoms in Alzheimer's patients, such as agitation or emotional lability, but this should be done under careful medical supervision.